Aurora Cannabis Inc. (ACB)
Should You Buy ACB Stock After Marijuana Reclassification Order?
Aurora Cannabis faces uneven gains from marijuana reclassification as medical cannabis drives growth, while weak consumer sales affect optimism.
2 Marijuana Stocks To Watch For Better Investing In 2026
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-term opportunities for marijuana stock investors and those looking to get invested in the industry. Cannabis stocks benefit from increasing consumer demand and acceptance. Medical cannabis adoption supports consistent revenue and defensive market positioning.
3 Marijuana Stocks To Watch In 2026
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. After years of regulatory uncertainty, capital constraints, and volatile price action, relief is being shown. The legal cannabis market is showing clear signs of structural improvement driven by policy reform, consolidation, and expanding global demand.
Marijuana Stocks To Watch After The Holidays
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. While 2025 seemed to be a transition year, 2026 could mark another pivot point. Specifically, one where improved business operations begin to consistently translate into stronger equity valuations across the sector. Investor sentiment may also shift meaningfully.
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Trulieve CEO Kim Rivers reacts to marijuana being reclassified
Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.
Trump signs executive order to reschedule marijuana, expand access to CBD products
President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use.
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.
3 Canadian Marijuana Stocks To Watch In 2026 That Could See A Massive Run
With 2026 showing to be a big year for reform, how will this impact marijuana stocks? Looking back over the years, it is clear that marijuana stocks have seen their best trading when positive news on reform is released. The speculation of what could happen drives the market action up often. If investors feel the reform is important enough, you'll then see some increased buying action.
3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overturned the Hemp laws in the USA. Many legal operators produced hemp and CBD products to ensure compliance under the bill as a way to energetically take part in the industry. Now, legal operators in legal states cultivating cannabis vs hemp have an entirely different legal road map to follow. Yet this is what many are calling a step backwards, and rightfully so.
Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.
